VANESSA COX: Open Payments
NPI 1912528001 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,757 in 79 payments from 18 companies in 2025. Trend: 2023 $2,181 · 2024 $2,065 · 2025 $1,757
Food & beverage: $1,683Education: $74
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $361 |
| Regeneron Healthcare Solutions, Inc. | 11 | $339 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $168 |
| CSL Behring | 6 | $148 |
| Amgen Inc. | 6 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Octapharma USA, Inc. | 3 | $85 |
| Verona Pharma, Inc. | 3 | $67 |
| GENZYME CORPORATION | 3 | $66 |
| GlaxoSmithKline, LLC. | 4 | $63 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, CUVITRU, PANZYGA, Rhapsido, Ohtuvayre, HYQVIA.
Industry payments across KY — which companies pay providers there.
